In patients with AIDS, a high CD8+ cell count and age younger than 36 years are risk factors for sulfonamide-induced skin reactions, according to a report published in the July issue of the Journal of the American Academy of Dermatology.
Dr. Eric Caumes, from H pital de la Piti Salp tri re in Paris, and colleagues analyzed risk factors for sulfonamide-induced skin reactions in 136 patients with AIDS. The patients had been hospitalized for pneumocystosis or toxoplasmosis and had received sulfonamide as part of their treatment regimen.
Thirty-six percent of patients experienced a cutaneous drug reaction, the authors note. Patients with a CD8+ cell count greater than 460 cells/microliter and those younger than 36 years were 3.5 and 2.1 times as likely, respectively, to experience a drug eruption than their counterparts. Contrary to previous reports, glutathione deficiency, slow acetylation status, and active viral infections had no bearing on the risk of a sulfonamide skin reaction. Moreover, corticosteroid use did not prevent the development of such reactions.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!